Simplex Trading’s Neumora Therapeutics NMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17K Sell
28,501
-171,309
-86% -$237K ﹤0.01% 7196
2026
Q2
$340K Buy
199,810
+70,654
+55% +$135K ﹤0.01% 4081
2026
Q1
$252K Buy
+129,156
New +$335K ﹤0.01% 4021
2025
Q4
– Sell
-8,501
Closed -$18.6K – 9544
2025
Q3
$15K Buy
+8,501
New +$13.7K ﹤0.01% 7594
2025
Q2
– Sell
-3,880
Closed -$2.94K – 9381
2025
Q1
$3K Sell
3,880
-7,804
-67% -$13.4K ﹤0.01% 7841
2024
Q4
$123K Buy
+11,684
New +$140K ﹤0.01% 4987
2024
Q3
– Sell
-5,221
Closed -$60.9K – 9202
2024
Q2
$51K Buy
5,221
+2,372
+83% +$24.5K ﹤0.01% 6064
2024
Q1
$39K Buy
+2,849
New +$46.1K ﹤0.01% 6502

Other funds holding NMRA

Simplex Trading's NMRA Position: Q3 2026 in Review

Simplex Trading reduced its Neumora Therapeutics (NMRA) stake by 86% in Q3 2026, selling an estimated $237K and leaving 28,501 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #7196.

Simplex Trading first reported a position in NMRA in Q1 2024 and has held it in 8 quarters since. The position peaked at $340K in Q2 2026. 127 funds tracked by Wall St. Rank hold NMRA as of Q3 2026.

  • Simplex Trading held 28,501 shares of Neumora Therapeutics worth $17K as of Q3 2026.
  • Simplex Trading sold 171,309 Neumora Therapeutics shares in Q3 2026, an estimated $237K.
  • Neumora Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #7196 holding.
  • Simplex Trading first reported a position in Neumora Therapeutics in Q1 2024 and has held it in 8 quarters since.
  • Simplex Trading's Neumora Therapeutics position peaked at $340K in Q2 2026.
  • 127 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.